BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review. Neurocrit Care. 2021;34:1062-1071. [PMID: 32661794 DOI: 10.1007/s12028-020-01049-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 44.0] [Reference Citation Analysis]
Number Citing Articles
1 da Silva Júnior RT, Santos Apolonio J, Cuzzuol BR, da Costa BT, Silva CS, Araújo GRL, Silva Luz M, Marques HS, Santos LKS, Pinheiro SLR, Lima de Souza Gonçalves V, Calmon MS, Freire de Melo F. COVID-19 neuropsychiatric repercussions: Current evidence on the subject. World J Methodol 2022; 12(5): 365-380 [DOI: 10.5662/wjm.v12.i5.365] [Reference Citation Analysis]
2 Parcial ALN, Salomão NG, Portari EA, Arruda LV, de Carvalho JJ, de Matos Guedes HL, Conde TC, Moreira ME, Batista MM, Paes MV, Rabelo K, Gomes-silva A. SARS-CoV-2 Is Persistent in Placenta and Causes Macroscopic, Histopathological, and Ultrastructural Changes. Viruses 2022;14:1885. [DOI: 10.3390/v14091885] [Reference Citation Analysis]
3 David J, Stara V, Hradsky O, Tuckova J, Slaba K, Jabandziev P, Sasek L, Huml M, Zidkova I, Pavlicek J, Palatova A, Klaskova E, Banszka K, Terifajova E, Vyhnanek R, Bloomfield M, Fingerhutova S, Dolezalova P, Prochazkova L, Chramostova G, Fencl F, Lebl J. Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic. Eur J Pediatr. [DOI: 10.1007/s00431-022-04593-7] [Reference Citation Analysis]
4 Martini AL, Carli G, Kiferle L, Piersanti P, Palumbo P, Morbelli S, Calcagni ML, Perani D, Sestini S. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. Eur J Nucl Med Mol Imaging 2022. [PMID: 35984451 DOI: 10.1007/s00259-022-05942-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Smith CJ, Renshaw P, Yurgelun-todd D, Sheth C. Acute and chronic neuropsychiatric symptoms in novel coronavirus disease 2019 (COVID-19) patients: A qualitative review. Front Public Health 2022;10:772335. [DOI: 10.3389/fpubh.2022.772335] [Reference Citation Analysis]
6 Parodi C, Viganò I, Ottaviano E, Massa V, Borghi E, Beretta S, Di Francesco JC, Badioni V, Vignoli A. Long-term analysis of the effects of COVID-19 in people with epilepsy: results from a multicenter on-line survey across the pandemic waves. Epilepsy & Behavior 2022. [DOI: 10.1016/j.yebeh.2022.108900] [Reference Citation Analysis]
7 Alnahdi MA, Alkharashi M. Ocular manifestations of COVID-19 in the pediatric age group. Eur J Ophthalmol 2022;:11206721221116210. [PMID: 35898182 DOI: 10.1177/11206721221116210] [Reference Citation Analysis]
8 Guzik A, Wolan-Nieroda A, Kochman M, Perenc L, Drużbicki M. Impact of mild COVID-19 on balance function in young adults, a prospective observational study. Sci Rep 2022;12:12181. [PMID: 35842493 DOI: 10.1038/s41598-022-16397-8] [Reference Citation Analysis]
9 Fazil M, Nikhat S. Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory viral illnesses: Phytochemical & pharmacological perspective. J Ethnopharmacol 2022;297:115526. [PMID: 35843408 DOI: 10.1016/j.jep.2022.115526] [Reference Citation Analysis]
10 Huang H, Chen J, Fang S, Chen X, Pan X, Lei H, Zhang Y, Lin H, Yuan Q, Xia P, Liu N, Du H. Association Between Previous Stroke and Severe COVID-19: A Retrospective Cohort Study and an Overall Review of Meta-Analysis. Front Neurol 2022;13:922936. [DOI: 10.3389/fneur.2022.922936] [Reference Citation Analysis]
11 Yang RC, Huang K, Zhang HP, Li L, Tan C, Chen HC, Jin ML, Wang XR. Transcriptional landscape of human neuroblastoma cells in response to SARS-CoV-2. BMC Neurosci 2022;23:43. [PMID: 35794518 DOI: 10.1186/s12868-022-00728-6] [Reference Citation Analysis]
12 Sachdeva M, Agarwal A, Sra HK, Rana M, Pradhan P, Singh M, Saini S, Singh M. Multisystem Inflammatory Syndrome Associated With COVID-19 in Children (MIS-C): A Systematic Review of Studies From India. Indian Pediatr 2022;59:563-9. [DOI: 10.1007/s13312-022-2559-5] [Reference Citation Analysis]
13 Liu C, Yan W, Shi J, Wang S, Peng A, Chen Y, Huang K. Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19. Front Nutr 2022;9:927092. [DOI: 10.3389/fnut.2022.927092] [Reference Citation Analysis]
14 Khan S, Nabi G, Ullah MW. Editorial: Neurological Disorders and COVID-19: Interconnections, Molecular Links, and Therapeutic Perspectives. Front Med (Lausanne) 2022;9:928912. [PMID: 35712118 DOI: 10.3389/fmed.2022.928912] [Reference Citation Analysis]
15 Conway SE, Healy BC, Zurawski J, Severson C, Kaplan T, Stazzone L, Galetta K, Chitnis T, Houtchens MK. COVID-19 severity is associated with worsened neurological outcomes in Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103946] [Reference Citation Analysis]
16 Naidu SA, Clemens RA, Naidu AS. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control. Journal of Dietary Supplements. [DOI: 10.1080/19390211.2022.2075072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Galluzzo V, Ciciarello F, Tosato M, Zazzara MB, Pais C, Savera G, Calvani R, Picca A, Marzetti E, Landi F; Gemelli Against COVID-19 Post-Acute Care Team. ASSOCIATION BETWEEN VITAMIN D STATUS AND PHYSICAL PERFORMANCE IN COVID-19 SURVIVORS: RESULTS FROM THE GEMELLI AGAINST COVID-19 POST-ACUTE CARE PROJECT. Mech Ageing Dev 2022;:111684. [PMID: 35568146 DOI: 10.1016/j.mad.2022.111684] [Reference Citation Analysis]
18 Silberberg E, Filep JG, Ariel A. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis. Front Immunol 2022;13:863449. [DOI: 10.3389/fimmu.2022.863449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Esmaeili S, Abbasi MH, Joghataei MT, Mirzaasgari Z, Emamikhah M, Makiani MJ, Nazarian H. Acute disseminated encephalitis (ADEM) as the first presentation of COVID-19; a case report. Ann Med Surg (Lond) 2022;77:103511. [PMID: 35369575 DOI: 10.1016/j.amsu.2022.103511] [Reference Citation Analysis]
20 Zhang R, Sun C, Chen X, Han Y, Zang W, Jiang C, Wang J, Wang J. COVID-19-Related Brain Injury: The Potential Role of Ferroptosis. JIR 2022;Volume 15:2181-98. [DOI: 10.2147/jir.s353467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Yevgi R, Bilge N. Comparison of electrodiagnostic findings in patients with post-COVID-19 and non-COVID-19 Guillain-Barre syndrome. Journal of Health Sciences and Medicine 2022;5:539-43. [DOI: 10.32322/jhsm.1054313] [Reference Citation Analysis]
22 Espiritu AI, Reyes NGD, Leochico CFD, Sy MCC, Villanueva Iii EQ, Anlacan VMM, Jamora RDG. Body mass index and its association with COVID-19 clinical outcomes: Findings from the Philippine CORONA study. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.03.013] [Reference Citation Analysis]
23 Quarleri J, Delpino MV. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients. Geroscience 2022. [PMID: 35157210 DOI: 10.1007/s11357-022-00528-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sen S, Samanta M, Biswas A, Sinhamahapatra TK. Orofacial dyskinesia with choreoathetoid movements caused by brainstem encephalitis: A rare complication of SARS-CoV-2-related multisystem inflammatory syndrome in children. J Paediatr Child Health 2022. [PMID: 35148008 DOI: 10.1111/jpc.15902] [Reference Citation Analysis]
25 Mahboubi Mehrabani M, Karvandi MS, Maafi P, Doroudian M. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Rev Med Virol 2022;:e2334. [PMID: 35138001 DOI: 10.1002/rmv.2334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Kannan V, Risen S. Posterior Reversible Encephalopathy Syndrome in a Child with Sickle Cell Disease and SARS-CoV-2 Infection. Journal of Pediatric Neurology. [DOI: 10.1055/s-0041-1742249] [Reference Citation Analysis]
27 Mariani C, Borgonovo F, Capetti AF, Oreni L, Cossu MV, Pellicciotta M, Armiento L, Bocchio S, Dedivitiis G, Lupo A, Galli M, Rizzardini G. Persistence of Long-COVID symptoms in a heterogenous prospective cohort. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.01.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Favieri F, Forte G, Agostini F, Giovannoli J, Di Pace E, Langher V, Tambelli R, Pazzaglia M, Giannini AM, Casagrande M. The Cognitive Consequences of the COVID-19 Pandemic on Members of the General Population in Italy: A Preliminary Study on Executive Inhibition. J Clin Med 2021;11:170. [PMID: 35011912 DOI: 10.3390/jcm11010170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Williamson CA, Faiver L, Nguyen AM, Ottenhoff L, Rajajee V. Incidence, Predictors and Outcomes of Delirium in Critically Ill Patients With COVID-19. Neurohospitalist 2022;12:31-7. [PMID: 34950384 DOI: 10.1177/19418744211034815] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Ku MW, Authié P, Bourgine M, Anna F, Noirat A, Moncoq F, Vesin B, Nevo F, Lopez J, Souque P, Blanc C, Fert I, Chardenoux S, Lafosse L, Cussigh D, Hardy D, Nemirov K, Guinet F, Langa Vives F, Majlessi L, Charneau P. Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice. EMBO Mol Med 2021;13:e14459. [PMID: 34647691 DOI: 10.15252/emmm.202114459] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
31 Hassani S, Lazem M, Jafari Z. No lasting impact of Covid-19 on the auditory system: a prospective cohort study. J Laryngol Otol 2021;135:1063-8. [DOI: 10.1017/s002221512100267x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Tan HW, Xu YM, Lau ATY. Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications. Expert Rev Proteomics 2021;18:925-38. [PMID: 34812694 DOI: 10.1080/14789450.2021.2010549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 García S, Cuatepotzo-Burgos FM, Toledo-Lozano CG, Balderrama-Soto A, Alcaraz-Estrada SL, Montiel-López L, De la Vega-Bravo AH, Mondragón-Terán P, Santosbeña-Lagunes M, Escarela-Serrano M, Rodríguez-Martínez CM, Méndez-Vidrio MDC, Muñoz-López S, Merino-Rajme JA, Rodríguez-Briseño RA, Cerda-Téllez F, Coral-Vázquez RM, Sauri-Suárez S, Quiñonez-Aguilar S, Pineda-Juárez JA, Suárez-Cuenca JA. Neurological Manifestations and Outcomes in a Retrospective Cohort of Mexican Inpatients with SARS-CoV-2 Pneumonia: Design of a Risk Profile. Healthcare (Basel) 2021;9:1501. [PMID: 34828547 DOI: 10.3390/healthcare9111501] [Reference Citation Analysis]
34 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Reference Citation Analysis]
35 Attia AS, Hussein M, Aboueisha MA, Omar M, Youssef MR, Mankowski N, Miller M, Munshi R, Swinford A, Kline A, Nguyen T, Toraih E, Duchesne J, Kandil E. Altered mental status is a predictor of poor outcomes in COVID-19 patients: A cohort study. PLoS One 2021;16:e0258095. [PMID: 34610034 DOI: 10.1371/journal.pone.0258095] [Reference Citation Analysis]
36 Stellema N, Absalom AR. Editorial: Neuroanaesthesiology editorial. Curr Opin Anaesthesiol 2021;34:553-5. [PMID: 34325460 DOI: 10.1097/ACO.0000000000001052] [Reference Citation Analysis]
37 Chmiela T, Rzepka M, Krzystanek E, Gorzkowska A. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report. Medicina (Kaunas) 2021;57:775. [PMID: 34440980 DOI: 10.3390/medicina57080775] [Reference Citation Analysis]
38 Motolese F, Ferrante M, Rossi M, Magliozzi A, Sbarra M, Ursini F, Marano M, Capone F, Travaglino F, Antonelli Incalzi R, Di Lazzaro V, Pilato F. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature. J Neurol 2021. [PMID: 34291313 DOI: 10.1007/s00415-021-10709-0] [Reference Citation Analysis]
39 Melkumyants A, Buryachkovskaya L, Lomakin N, Antonova O, Serebruany V. Mild COVID-19 and Impaired Blood Cell-Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics? Thromb Haemost 2021. [PMID: 34482535 DOI: 10.1055/a-1551-9911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Köseoğlu Toksoy C, Yavuz T, Orhan S, Şarlak Konya P, Korkmaz D, Tünay H, Bozkurt E, Coşğun İG, Demirtürk N, Doğan İ, Türk Börü Ü. Neurological symptoms and findings in COVID-19: a prospective clinical study. Neurol Res 2021;:1-6. [PMID: 34269161 DOI: 10.1080/01616412.2021.1952740] [Reference Citation Analysis]
41 Sideris GA, Nikolakea M, Karanikola A, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. WJR 2021;13:193-223. [DOI: 10.4329/wjr.v13.i6.193] [Reference Citation Analysis]
42 Sideris GA, Nikolakea M, Karanikola AE, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. World J Radiol 2021; 13(6): 192-222 [PMID: 34249239 DOI: 10.4329/wjr.v13.i6.192] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
43 Damiano RF, Guedes BF, de Rocca CC, de Pádua Serafim A, Castro LHM, Munhoz CD, Nitrini R, Filho GB, Miguel EC, Lucchetti G, Forlenza O. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci 2021. [PMID: 34173049 DOI: 10.1007/s00406-021-01286-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
44 Awogbindin IO, Ben-Azu B, Olusola BA, Akinluyi ET, Adeniyi PA, Di Paolo T, Tremblay MÈ. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease. Front Cell Neurosci 2021;15:670298. [PMID: 34211370 DOI: 10.3389/fncel.2021.670298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
45 Siracusa L, Cascio A, Giordano S, Medaglia AA, Restivo GA, Pirrone I, Saia GF, Collura F, Colomba C. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature. Ital J Pediatr 2021;47:123. [PMID: 34078441 DOI: 10.1186/s13052-021-01066-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
46 LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, Walker TC, Singh AR, Dapul H, Hobbs CV, McLaughlin GE, Son MBF, Maddux AB, Clouser KN, Rowan CM, McGuire JK, Fitzgerald JC, Gertz SJ, Shein SL, Munoz AC, Thomas NJ, Irby K, Levy ER, Staat MA, Tenforde MW, Feldstein LR, Halasa NB, Giuliano JS Jr, Hall MW, Kong M, Carroll CL, Schuster JE, Doymaz S, Loftis LL, Tarquinio KM, Babbitt CJ, Nofziger RA, Kleinman LC, Keenaghan MA, Cvijanovich NZ, Spinella PC, Hume JR, Wellnitz K, Mack EH, Michelson KN, Flori HR, Patel MM, Randolph AG; Overcoming COVID-19 Investigators. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol 2021;78:536-47. [PMID: 33666649 DOI: 10.1001/jamaneurol.2021.0504] [Cited by in Crossref: 24] [Cited by in F6Publishing: 107] [Article Influence: 24.0] [Reference Citation Analysis]
47 Jiang F, Yang WL, Wang JW, Zhu Z, Luo C, Arendt-Nielsen L, Song XJ. Pain during and after coronavirus disease 2019: Chinese perspectives. Pain Rep 2021;6:e931. [PMID: 33997586 DOI: 10.1097/PR9.0000000000000931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Alamri HS, Mousa WF, Algarni A, Megahid SF, Al Bshabshe A, Alshehri NN, Bashah DM, Alosaimi R, Alshehri A, Alsamghan A, Alsabaani A. Mental Health of COVID-19 Patients-A Cross-Sectional Survey in Saudi Arabia. Int J Environ Res Public Health 2021;18:4758. [PMID: 33946978 DOI: 10.3390/ijerph18094758] [Reference Citation Analysis]
49 Parsons N, Outsikas A, Parish A, Clohesy R, D'Aprano F, Toomey F, Advani S, Poudel GR. Modelling the Anatomic Distribution of Neurologic Events in Patients with COVID-19: A Systematic Review of MRI Findings. AJNR Am J Neuroradiol 2021;42:1190-5. [PMID: 33888458 DOI: 10.3174/ajnr.A7113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
50 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
51 Vrillon A, Mhanna E, Aveneau C, Lebozec M, Grosset L, Nankam D, Albuquerque F, Razou Feroldi R, Maakaroun B, Pissareva I, Cherni Gherissi D, Azuar J, François V, Hourrègue C, Dumurgier J, Volpe-Gillot L, Paquet C. COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients. Alzheimers Res Ther 2021;13:77. [PMID: 33838684 DOI: 10.1186/s13195-021-00820-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
52 Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurol 2021;21:116. [PMID: 33726699 DOI: 10.1186/s12883-021-02152-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
53 Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, Heim B, Limmert V, Sahanic S, Pizzini A, Sonnweber T, Tancevski I, Scherfler C, Zamarian L, Bellmann-Weiler R, Weiss G, Djamshidian A, Kiechl S, Seppi K, Loeffler-Ragg J, Pfausler B, Helbok R. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol 2021. [PMID: 33682276 DOI: 10.1111/ene.14803] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
54 Gherlone EF, Polizzi E, Tetè G, De Lorenzo R, Magnaghi C, Rovere Querini P, Ciceri F. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19. J Dent Res 2021;100:464-71. [PMID: 33655804 DOI: 10.1177/0022034521997112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
55 Jarkovsky J, Benesova K, Cerny V, Razova J, Kala P, Dolina J, Majek O, Sebestova S, Bezdekova M, Melicharova H, Snajdrova L, Dusek L, Parenica J. Covidogram as a simple tool for predicting severe course of COVID-19: population-based study. BMJ Open 2021;11:e045442. [PMID: 33622955 DOI: 10.1136/bmjopen-2020-045442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 El-Sayed A, Aleya L, Kamel M. COVID-19: a new emerging respiratory disease from the neurological perspective. Environ Sci Pollut Res Int 2021;28:40445-59. [PMID: 33590398 DOI: 10.1007/s11356-021-12969-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
57 Ranganathan C, Fusinski SD, Obeid IM, Ismail KM, Ferguson DT, Raminick MF, Dawes SM. Therapeutic plasma exchange for persistent encephalopathy associated with Covid-19. eNeurologicalSci 2021;22:100327. [PMID: 33585705 DOI: 10.1016/j.ensci.2021.100327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tonacci A, Billeci L, Di Mambro I, Marangoni R, Sanmartin C, Venturi F. Wearable Sensors for Assessing the Role of Olfactory Training on the Autonomic Response to Olfactory Stimulation. Sensors (Basel) 2021;21:770. [PMID: 33498830 DOI: 10.3390/s21030770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
60 Parsamanesh N, Pezeshgi A, Hemmati M, Jameshorani M, Saboory E. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19. Int J Neurosci 2021;:1-8. [PMID: 33175635 DOI: 10.1080/00207454.2020.1849193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
61 Ghaffari M, Ansari H, Beladimoghadam N, Aghamiri SH, Haghighi M, Nabavi M, Mansouri B, Mehrpour M, Assarzadegan F, Hesami O, Sedaghat M, Farahbakhsh M, Lima BS. Neurological features and outcome in COVID-19: dementia can predict severe disease. J Neurovirol 2021;27:86-93. [PMID: 33417193 DOI: 10.1007/s13365-020-00918-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
62 Mayi BS, Leibowitz JA, Woods AT, Ammon KA, Liu AE, Raja A. The role of Neuropilin-1 in COVID-19. PLoS Pathog 2021;17:e1009153. [PMID: 33395426 DOI: 10.1371/journal.ppat.1009153] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 18.0] [Reference Citation Analysis]
63 Kumar A, Zhou L, Zhi K, Raji B, Pernell S, Tadrous E, Kodidela S, Nookala A, Kochat H, Kumar S. Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles. Int J Mol Sci 2020;22:E138. [PMID: 33375558 DOI: 10.3390/ijms22010138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
64 Khiali S, Rezagholizadeh A, Entezari-Maleki T. A comprehensive review on sarilumab in COVID-19. Expert Opin Biol Ther 2021;21:615-26. [PMID: 33161757 DOI: 10.1080/14712598.2021.1847269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
65 Zimmer A, Youngblood A, Adnane A, Miller BJ, Goldsmith DR. Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic. Brain Behav Immun 2021;91:756-70. [PMID: 33152446 DOI: 10.1016/j.bbi.2020.10.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
66 Wang F, Kream RM, Stefano GB. Long-Term Respiratory and Neurological Sequelae of COVID-19. Med Sci Monit 2020;26:e928996. [PMID: 33177481 DOI: 10.12659/MSM.928996] [Cited by in Crossref: 18] [Cited by in F6Publishing: 81] [Article Influence: 9.0] [Reference Citation Analysis]
67 Parsons N, Outsikas A, Parish A, Clohesy R, Thakkar N, D'Aprano F, Toomey F, Advani S, Poudel G. Modelling the Anatomical Distribution of Neurological Events in COVID-19 Patients: A Systematic Review. medRxiv 2020:2020. [PMID: 33106811 DOI: 10.1101/2020.10.21.20215640] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Lad SS, Kait SP, Suryawanshi PB, Mujawar J, Lad P, Khetre R, Jadhav LM, Bhor A, Balte P, Kataria P, Saifi MS, Kazi S. Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS). Indian J Pediatr 2021;88:294-5. [PMID: 33078283 DOI: 10.1007/s12098-020-03530-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hu J, Jolkkonen J, Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses. Neurosci Biobehav Rev 2020;119:184-93. [PMID: 33091416 DOI: 10.1016/j.neubiorev.2020.10.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
70 Mukhopadhyay D, Mussa BM. Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis. Brain Sci 2020;10:E666. [PMID: 32992681 DOI: 10.3390/brainsci10100666] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
71 Bihlmaier K, Coras R, Willam C, Grampp S, Jabari S, Eichhorn P, Haller F, Kuramatsu J, Schwab S, Castellanos I, Birkholz T, Schüttler J, Altmeppen J, Schiffer M, Herbst L. Disseminated Multifocal Intracerebral Bleeding Events in Three Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation As Rescue Therapy. Crit Care Explor 2020;2:e0218. [PMID: 32984837 DOI: 10.1097/CCE.0000000000000218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
72 Aslam M, Ladilov Y. Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection. Cells 2020;9:E1962. [PMID: 32854430 DOI: 10.3390/cells9091962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
73 Fayed I, Pivazyan G, Conte AG, Chang J, Mai JC. Intracranial hemorrhage in critically ill patients hospitalized for COVID-19. J Clin Neurosci 2020;81:192-5. [PMID: 33222915 DOI: 10.1016/j.jocn.2020.08.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
74 Nami M, Gadad BS, Chong L, Ghumman U, Misra A, Gadad SS, Kumar D, Perry G, Abraham SJK, Rao KS. The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies. J Clin Med 2020;9:E2624. [PMID: 32823540 DOI: 10.3390/jcm9082624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]